CS
PFE icon

Comerica Securities’s Pfizer PFE Stock Holding History

Comerica Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.96M Sell
59,225
-56,802
-49% -$2.01M 0.16% 134
2023
Q2 		$4.26M Buy
116,027
+1,656
+1% +$64.5K 0.3% 91
2023
Q1 		$4.67M Buy
114,371
+40,979
+56% +$1.77M 0.34% 84
2022
Q4 		$3.76M Buy
73,392
+8,567
+13% +$411K 0.27% 103
2022
Q3 		$2.84M Buy
64,825
+14,073
+28% +$684K 0.23% 106
2022
Q2 		$2.66M Buy
50,752
+5,624
+12% +$287K 0.2% 119
2022
Q1 		$2.34M Buy
45,128
+4,946
+12% +$257K 0.16% 137
2021
Q4 		$2.37M Sell
40,182
-5,350
-12% -$265K 0.15% 138
2021
Q3 		$1.96M Sell
45,532
-8,127
-15% -$360K 0.14% 147
2021
Q2 		$2.1M Sell
53,659
-38,009
-41% -$1.48M 0.16% 133
2021
Q1 		$3.32M Buy
91,668
+31,979
+54% +$1.14M 0.25% 97
2020
Q4 		$2.2M Sell
59,689
-624
-1% -$22.9K 0.18% 116
2020
Q3 		$2.1M Sell
60,313
-6,106
-9% -$214K 0.19% 114
2020
Q2 		$2.06M Sell
66,419
-870
-1% -$29.6K 0.19% 114
2020
Q1 		$2.08M Sell
67,289
-6,129
-8% -$209K 0.23% 106
2019
Q4 		$2.73M Sell
73,418
-385
-0.5% -$13.7K 0.26% 95
2019
Q3 		$2.52M Buy
73,803
+13,615
+23% +$495K 0.26% 98
2019
Q2 		$2.47M Sell
60,188
-48,496
-45% -$1.93M 0.26% 95
2019
Q1 		$4.38M Sell
108,684
-7,138
-6% -$286K 0.49% 55
2018
Q4 		$4.8M Sell
115,822
-5,265
-4% -$219K 0.63% 38
2018
Q3 		$5.06M Buy
121,087
+774
+0.6% +$29.8K 0.59% 39
2018
Q2 		$4.14M Buy
120,313
+3,997
+3% +$137K 0.5% 45
2018
Q1 		$3.92M Buy
116,316
+1,766
+2% +$60.7K 0.49% 49
2017
Q4 		$3.94M Buy
114,550
+3,455
+3% +$118K 0.5% 52
2017
Q3 		$3.76M Buy
111,095
+87,707
+375% +$2.82M 0.52% 46
2017
Q2 		$745K Sell
23,388
-1,892
-7% -$59.7K 0.11% 207
2017
Q1 		$821K Buy
+25,280
New +$797K 0.13% 189
2015
Q1 		– Sell
-10,365
Closed -$306K – 316
2014
Q4 		$306K Sell
10,365
-697
-6% -$20K 0.19% 100
2014
Q3 		$310K Buy
+11,062
New +$310K 0.21% 110

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Comerica Securities's PFE Position: Q3 2023 in Review

Comerica Securities reduced its Pfizer (PFE) stake by 49% in Q3 2023, selling an estimated $2.01M and leaving 59,225 shares worth $1.96M. The position accounts for 0.16% of the portfolio, ranked #134.

Comerica Securities first reported a position in PFE in Q3 2014 and has held it in 29 quarters since. The position peaked at $5.06M in Q3 2018. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Comerica Securities held 59,225 shares of Pfizer worth $1.96M as of Q3 2023.
  • Comerica Securities sold 56,802 Pfizer shares in Q3 2023, an estimated $2.01M.
  • Pfizer made up 0.16% of Comerica Securities's portfolio in Q3 2023, its #134 holding.
  • Comerica Securities first reported a position in Pfizer in Q3 2014 and has held it in 29 quarters since.
  • Comerica Securities's Pfizer position peaked at $5.06M in Q3 2018.
  • 2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.